Literature DB >> 11598321

Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors.

J K Ness1, M J Romanko, R P Rothstein, T L Wood, S W Levison.   

Abstract

Hypoxia-ischemia (HI) is a leading cause of white matter damage, a major contributor to cerebral palsy in premature infants. Preferential white matter damage is believed to result from vulnerability of the immature oligodendrocyte (the pro-OL) to factors elevated during ischemic damage, such as oxygen free radicals and glutamate. In order to determine whether pro-OLs undergo apoptotic death after HI, we analyzed periventricular white matter OLs in P7 rats 4, 12 and 24 h after HI to analyze the time course and mode of cell death. DNA fragmentation was seen at 12 and 24 h of recovery after HI, representing a 17-fold increase over control. In addition, caspase-3 activation was found in NG2+ pro-OLs at 12 h. Electron-microscopic analysis of cell death in the white matter revealed a transition from early necrotic deaths to hybrid cell deaths to classical apoptosis between 4 and 24 h of recovery from HI. The delayed time course of apoptosis in pro-OLs supports the feasibility of interventions to improve clinical outcomes for newborns surviving birth asphyxia. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598321     DOI: 10.1159/000046144

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  37 in total

Review 1.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

2.  Hypoxia-Induced Iron Accumulation in Oligodendrocytes Mediates Apoptosis by Eliciting Endoplasmic Reticulum Stress.

Authors:  Gurugirijha Rathnasamy; Madhuvika Murugan; Eng-Ang Ling; Charanjit Kaur
Journal:  Mol Neurobiol       Date:  2015-08-29       Impact factor: 5.590

3.  Towards improved animal models of neonatal white matter injury associated with cerebral palsy.

Authors:  John C Silbereis; Eric J Huang; Stephen A Back; David H Rowitch
Journal:  Dis Model Mech       Date:  2010 Nov-Dec       Impact factor: 5.758

4.  Rapid auditory processing and learning deficits in rats with P1 versus P7 neonatal hypoxic-ischemic injury.

Authors:  Melissa M McClure; Steven W Threlkeld; Glenn D Rosen; R Holly Fitch
Journal:  Behav Brain Res       Date:  2006-06-12       Impact factor: 3.332

Review 5.  Normal development of brain circuits.

Authors:  Gregory Z Tau; Bradley S Peterson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

6.  Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia.

Authors:  Daniel J Webber; Marka van Blitterswijk; Siddharthan Chandran
Journal:  Am J Pathol       Date:  2009-10-22       Impact factor: 4.307

Review 7.  Neonatal brain hemorrhage (NBH) of prematurity: translational mechanisms of the vascular-neural network.

Authors:  Tim Lekic; Damon Klebe; Roy Poblete; Paul R Krafft; William B Rolland; Jiping Tang; John H Zhang
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

8.  Mechanisms of mouse neural precursor expansion after neonatal hypoxia-ischemia.

Authors:  Krista D Buono; Matthew T Goodus; Mariano Guardia Clausi; Yuhui Jiang; Dean Loporchio; Steven W Levison
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

Review 9.  Systemic prenatal insults disrupt telencephalon development: implications for potential interventions.

Authors:  Shenandoah Robinson
Journal:  Epilepsy Behav       Date:  2005-08-02       Impact factor: 2.937

10.  TGFbeta1 stimulates the over-production of white matter astrocytes from precursors of the "brain marrow" in a rodent model of neonatal encephalopathy.

Authors:  Jennifer M Bain; Amber Ziegler; Zhengang Yang; Steven W Levison; Ellora Sen
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.